Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles

Environmental Health Perspectives

Volumn 113, Issue 7, 2005, Pages 823-839

  Oberdörster, Günter ^a   Oberdörster, Eva ^b   Oberdörster, Jan ^c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c BAYER CROPSCIENCE   (United States)

Author keywords

Biokinetics; Central nervous system; Engineered nanomaterials; Environmental health; Human health; Nanosized particles; Respiratory tract; Risk assessment; Skin; Ultrafine particles

Indexed keywords

NANOPARTICLE;

AIRBORNE PARTICLE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; BIOINFORMATICS; BLOOD FLOW; BONE MARROW; CELL INTERACTION; CELL STRUCTURE; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; COATED PARTICLE; DENDRITE; DIFFUSION; ECOTOXICITY; ENDOCYTOSIS; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GANGLION; HEALTH HAZARD; HEART; HUMAN; IN VIVO STUDY; KINETICS; LYMPH FLOW; LYMPH NODE; LYMPHATIC SYSTEM; MEDICINE; MITOCHONDRION; MOLECULAR BIOLOGY; NANOTECHNOLOGY; NERVE FIBER; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; RISK ASSESSMENT; SPLEEN; TOXICOLOGY; TRANSCYTOSIS;

AEROSOLS; ANIMALS; DUST; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; RISK ASSESSMENT; TOXICOLOGY;

EID: 20644449754     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7339     Document Type: Review

References (188)

1. Adams RJ, Bray D. 1983. Rapid transport of foreign particles microinjected into crab axons. Nature 303:718-720.
2. Akerman MA, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617-12621.
3. Amato I. 1989. Making the right stuff. Sci News 136:108-110.
4. Anderson PJ, Wilson JD, Hiller FC. 1990. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 97:1115-1120.
5. ANSI. 2004. Home page. American National Standards Institute. Available: http://www.ansi.org. [accessed 16 March 2005].
6. Arvidson B. 1994. A review of axonal transport of metals. Toxicology 88:1-14.
7. Auclair F, Baudot P, Beiler D, Limasset J. 1983. Accidents benines et mortetels dus aux "traitement" du polytetrafluoroethylene an millieu industrial: observations cliniques et measures physio-chemiques des atmosphere pollues. Toxicol Eur Res 1:43-48.
8. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Non-invasive imaging of quantum dots in mice. Bioconjug Chem 15:79-86.
9. Bazile DV, Ropert C, Huve P, Verrecchia T, Marlard M, Frydman A, et al. 1992. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13(15):1093-1102.
10. Bergeson LL, Auerbach B. 2004. The Environmental Regulatory Implications of Nanotechnology. Daily Environment Report No. 71. Washington, DC:Bureau of National Affairs, Inc. Available: http://www.lawbc.com/other_pdfs/The%20Environmental%20Regulatory %20Implications%20of%20N anotechnology.pdf [accessed 26 April 2005].
11. Berry JP, Arnoux B, Stanislas G, Galle P, Chretien J. 1977. A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine 27:354-357.
12. Blakemore R. 1975. Magnetotactic bacteria. Science 190:377-379.
13. Blundell G, Henderson WJ, Price EW. 1989. Soil particles in the tissues of the foot in endemic elephantiasis of the lower legs. Ann Trop Med Parasitol 83 (4):381-385.
14. Böckmann J, Lahl H, Eckert T, Unterhalt B. 2000. Titan-Blutspiegel vor und nach Belastungsversuchen mit Titandioxid [in German]. Pharmazie 55:140-143.
15. Bodian D, Howe HA. 1941a. Experimental studies on intraneural spread of poliomyelitis virus. Bull Johns Hopkins Hosp 69:248-267.
16. Bodian D, Howe HA. 1941b. The rate of progression of poliomyelitis virus in nerves. Bull Johns Hopkins Hosp 69:79-85.
17. Brand P, Gebhart J, Below M, Georgi B, Heyder J. 1991. Characterization of environmental aerosols on Helgoland Island. Atmos Environ 25A(3/4):581-585.
18. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K. 2000. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med 57:685-691.
19. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191-199.
20. Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240-1247.
21. Cagle DW, Kenmnel SJ, Mirzadeh S, Alford JM, Wilson LJ. 1999. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc Natl Acad Sci USA 96:5182-5187.
22. Calderon-Garcidueñas L, Azzarelli B, Acuna H, Garcia R, Gambling TM, Osnaya N, et al. 2002. Air pollution and brain damage. Toxicol Pathol 30(3):373-389.
23. Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, et al. 2005. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 26:133-140.
24. Cavagna G, Finulli M, Vigliani EC. 1961. Studio sperimentale sulla patogenesi della febre do inalazione di fumi di Teflon (politetrafluoroetilene) [in Italian]. Med Lavoro 52:251-261.
25. Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. 2004. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect 112:879-882.
26. Chen B, Wilson S, Das M, Coughlin D, Erlanger B. 1998. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci USA 95:10809-10813.
27. Cheng X, Kan A, Tomson M. 2004. Napthalone adsorption and desorption from aqueous C60 fullerene. J Chem Engineer Data 49:675-678.
28. 2 induced by UV, gamma-ray and electron beams. Chemosphere 50:1007-1013.
29. Cohen A, Hnasko R, Schubert W, Lisanti M. 2004. Role of caveolae and caveolins in health and disease. Physiol Rev 84:1341-1379.
30. Coleman WE, Scheel LD, Gorski CH. 1968. The particle resulting from polytetrafluorethylene (PTFE) pyrolysis in air. AIHA J 29:54-60.
31. Corachan M, Tura JM, Campo E, Soley M, Traveria A. 1988. Poedoconiosis in Aequatorial Guinea. Report of two cases from different geological environments. Trop Geogr Med 40:359-364.
32. Cyrys J, Stolzel M, Heinrich J, Kreyling WG, Menzel N, Wittmaack K, et al. 2003. Elemental composition and sources of fine and ultrafine ambient particles in Erfurt, Germany. Sci Tot Environ 305:143-156.
33. Daughton C, Ternes T. 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107(suppl 6):907-938.
34. de Lorenzo AJ. 1957. Electron microscopic observations of the olfactory mucosa and olfactory nerve. J Biophys Biochem Cytol 3:839-850.
35. de Lorenzo AJ. 1970. The olfactory neuron and the blood-brain barrier. In: Taste and Smell in Vertebrates (Wolstenholme G, Knight J, eds). London:Churchill, 151-176.
36. Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4(1):11-18.
37. Dieckmann G, Dalton A, Johnson P, Razal J, Chen J, Giordano GM, et al. 2003. Controlled assembly of carbon nanotubes by designed amphiphilic peptide helices. J Am Chem Soc 125:1770-1777.
38. Dobson J. 2001. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 496:1-5.
39. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al. 2002. The pulmonary toxicology of ultrafine particles. J Aerosol Med 15:213-220.
40. Donaldson K, Li XY, MacNee W. 1998. Ultrafine (nanometre) particle mediated lung injury. J Aerosol Sci 29:553-560.
41. Donaldson K, Stone V. 2003. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita 39:405-410.
42. Donaldson K, Tran C-L. 2002. Inflammation caused by particles and fibers. Inhal Toxicol 14:5-27.
43. Donlin M, Frey R, Putnam C, Proctor J, Bashkin J. 1998. Analysis of iron in ferritin, the iron-storage protein. J Chem Educ 75:437-41.
44. Driscoll KE. 1996. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 8(suppl):139-153.
45. Dunn JR, Fuller M, Zoeger J, Dobson J, Heller F, Hamnmann J, et al. 1995. Magnetic material in the human hippocampus. Brain Res Bull 36:149-153.
46. Elder ACP, Gelein R, Azadniv M, Frampton M, Finkelstein J, Oberdorster G. 2002. Systemic interactions between inhaled ultrafine particles and endotoxin. Ann Occup Hyg 46(suppl 1):231-234.
47. Elder ACP, Gelein R, Azadniv M, Frampton M, Finkelstein J, Oberdorster G. 2004. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol 16(6/7):461-471.
48. Elder ACP, Gelein R, Finkelstein JN, Cox C, Oberdörster G. 2000. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal Toxicol 12(suppl 4):227-246.
49. Essential Day Spa. 2005. Skin Anatomy and Physiology. Available: http://www.essentialdayspa.com/Skin_Anathomy_and_Physiology.htm [accessed 26 April 2005].
50. Evelyn A, Mannick S, Sermon PA. 2003. Unusual carbon-based nanofibers and chains among diesel-emitted particles. Nano Lett 3:63-64.
51. Fechter LD, Johnson DL, Lynch RA. 2002. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 23:177-183.
52. Feikert T, Mercer P, Corson N, Gelein R, Opanashuk L, Elder A, et al. 2004. Inhaled solid ultrafine particles (UFP) are efficiently translocated via neuronal naso-olfactory pathways [Abstract]. Toxicologist 78(suppl 1):435-436.
53. Ferin J, Oberdörster G. 1992. Translocation of particles from pulmonary alveoli into the interstitium. J Aerosol Med 5:179-187.
54. Ferin J, Oberdörster G, Penney DP. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am J Resp Cell Mol Biol 6:535-542.
55. Ferin J, Oberdörster G, Penney DP, Soderholm SC, Gelein R, Piper HC. 1990. Increased pulmonary toxicity of ultrafine particles? I. Particle clearance, translocation, morphology. J Aerosol Sci 21:381-384.
56. Ferin J, Oberdörster G, Soderholm SC, Gelein R. 1991. Pulmonary tissue access of ultrafine particles. J Aerosol Med 4(1):57-68.
57. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, et al. 2002. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 294:116-119.
58. Foresight and Governance Project. 2003. Nanotechnology & Regulation: A Case Study using the Toxic Substance Control Act (TSCA): A Discussion Paper. Publication 2003-6. Washington, DC:Woodrow Wilson International Center for Scholars. Available: http://www.nanotechcongress.com/Nanotech-Regulation.pdf [accessed 26 April 2005].
59. Fox JE, Starcevic M, Kow KY, Burow ME, McLachlan JA. 2001. Nitrogen fixation: endocrine disrupters and flavonoid signalling. Nature 413:128-129.
60. Freitas RA Jr. 1999. Nanomedicine, Volume I: Basic Capabilities. Georgetown, TX:Landes Bioscience.
61. Gianutsos G, Morrow GR, Morris JB. 1997. Accumulation of manganese in rat brain following intranasal administration. Fundam Appl Toxicol 37:102-105.
62. Gibaud S, Andreux JP, Weingarten C, Renard M, Couvreur P. 1994. Increased bone marrow toxicity of doxorubicin bound to nanoparticles. Eur J Cancer 30A:820-826.
63. Gibaud S, Demoy M, Andreux JP, Weingarten C, Gouritin B, Couvreur P. 1996. Cells involved in the capture of nanoparticles in hematopoietic organs. J Pharm Sci 85:944-950.
64. Gibaud S, Rousseau C, Weingarten C, Favier R, Douay L, Andreux JP, et al. 1998. Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF). J Control Release 52:131-139.
65. Goldstein M, Weiss H, Wade K, Penek J, Andrews L, Brandt-Rauf P. 1987. An outbreak of fume fever in an electronics instrument testing laboratory. J Occup Med 29:746-749.
66. Gopinath PG, Gopinath G, Kumar A. 1978. Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intranasal route of drug delivery. Curr Ther Res 23 (5):596-607.
67. Greim H, Borm P, Schins R, Donaldson K, Driscoll K, Hartwig A, et al. 2001. Toxicity of fibers and particles - report of the workshop held in Munich, Germany, 26-27 October 2000. Inhal Toxicol 13:737-754.
68. Griffith FD, Stephens SS, Tayfun FO. 1973. Exposure of Japanese quail and parakeets to the pyrolysis products of fry pans coated with teflon and common cooking oils. Am Ind Hyg Assoc J 34:176-178.
69. Gumbleton M. 2001. Caveolae as potential macromolecule trafficking compartments within alveolar epithelium. Adv Drug Deliv Rev 49:281-300.
70. Hautot D, Pankhurst QA, Khan N, Dobson J. 2003. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc R Soc Lon B 270(suppl 1):S62-S64.
71. Heckel K, Kiefmann R, Dorger M, Stoeckelhuber M, Goetz AE. 2004. Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol 287:L867-L878.
72. Henneberger A, Zareba W, Ibald-Mulli A, Ruckerl R, Cyrys J, Couderc JP, et al. 2005. Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Perspect 113:440-446.
73. Howe HA, Bodian D. 1940. Portals of entry of poliomyelitis virus in the chimpanzee. Proc Soc Exp Biol Med 43:718-721.
74. Huczko A, Lange H, Calko E, Grubek-Jaworska H, Droszcz P. 2001. Physiological testing of carbon nanotubes: are they asbestos-like? Fullerene Sci Technol 9:251-254.
75. Hughes LS, Cass GR, Gone J, Ames M, Olmez I. 1998. Physical and chemical characterization of atmospheric ultrafine particles in the Los Angeles area. Environ Sci Technol 32:1153-1161.
76. Hunter DD, Dey RD. 1998. Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium. Neuroscience 83:591-599.
77. Hunter DD, Undem BJ. 1999. Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am J Respir Crit Care Med 159:1943-1948.
78. IARC (International Agency for Research on Cancer). 2002. Manmade Vitreous Fibres. IARC Monogr Eval Carcinog Risks Hum 81:1-418.
79. ICON. 2004. International Council on Nanotechnology Home page. Available: http://icon.rice.edu [accessed 16 March 2005].
80. International Commission on Radiological Protection. 1994. Human respiratory model for radiological protection. Ann ICRP 24:1-300.
81. Jani P, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42:821-826
82. Jani PU, McCarthy DE, Florence AT. 1994. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm 105:157-168.
83. Jaques PA, Kim CS. 2000. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol 12:715-731.
84. Johnston CJ, Finkelstein JN, Mercer P, Corson N, Gelein R, Oberdorster G. 2000. Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 168:208-215.
85. Joo SH, Feitz AJ, Waite TD. 2004. Oxidative degradation of the carbothioate herbicide, molinate, using nanoscale zerovalent iron. Environ Sci Technol 38:2242-2247.
86. Kato T, Yashiro T, Murata Y, Herbert DC, Oshikawa K, Bando M, et al. 2003. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tiss Res 311:47-51.
87. Kennedy P, Chaudhuri A. 2002. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 73:237-238.
88. Keyhani K, Scherer PW, Mozell MM. 1997. A numerical model of nasal odorant transport for the analysis of human olfaction. J Theor Biol 186:279-301.
89. Kim S, Lim YS, Soltesz EG, De Grand AM, Lee J, Nakayama A, et al. 2004. Near infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22(1):93-97.
90. Kimbell JS, Godo MN, Gross EA, Joyner DR, Richardson RB, Morgan KT. 1997. Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol Appl Pharmacol 145:388-398.
91. Kirschvink JL, Kobayashi-Kirschvink A, Woodford BJ. 1992. Magnetite biomineralization in the human brain. Proc Natl Acad Sci USA 89:7683-7687.
92. Kirschvink J, Walker M, Diebel C. 2001. Magnetite-based magneto-reception. Curr Opin Neurobiol 11:462-468.
93. König MF, Lucocq JM, Webel ER. 1993. Demonstration of pulmonary vascular perfusion by electron and light microscopy. J Appl Physiol 75(4):1877-1883.
94. Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65-81.
95. Kreuter J. 2004. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotech 4:484-488.
96. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, et al. 2002. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317-325.
97. Kreyling WG, Scheuch G. 2000. Clearance of particles deposited in the lungs. In: Particle-Lung Interactions (Gehr P, Heyder J, eds). New York:Marcel Dekker Inc., 323-376.
98. Kreyling W, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, et al. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 65A:1513-1530.
99. Kulmala M. 2004. Formation and growth rates of ultrafine atmospheric particles: a review of observations. J Aerosol Sci 35:143-176.
100. Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126-134.
101. Lecoanet H, Bottero J, Wiesner M. 2004. Laboratory assessment of the mobility of nanomaterials in porous media. Environ Sci Technol 38:5164-5169.
102. Lecoanet H, Wiesner M. 2004. Velocity effects on fullerene and oxide nanoparticle deposition in porous media. Environ Sci Technol 38(16):4377-4382.
103. Lee CH, Guo YL, Tsai PJ, Chang HY, Chen CR, Chen CW, et al. 1997. Fatal acute pulmonary oedema after inhalation of fumes from polytetrafluoroethylene (PTFE). Eur Res J 10:1408-1411.
104. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. 2003. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111:455-460.
105. Li X, Brown D, Smith S, MacNee W, Donaldson K. 1999. Short-term nflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol 11:709-731.
106. Lu Q, Moore JM, Huang G, Mount AS, Rao AM, Larcom LL, et al. 2004. RNA polymer translocation with single-walled carbon nanotubes. Nano Lett 4:2473-2477.
107. Mach R. 2004. Nanoscale Particle Treatment of Groundwater. Federal Remedial Technology Roundtable: Naval Facilities Engineering Command. Available http://www.frtr.gov/pdf/meetings/l-mach_09jun04.pdf [accessed 16 March 2005].
108. Malmgren L, Olsson Y, Olsson T, Kristensson K. 1978. Uptake and retrograde axonal transport of various exogenous macromolecules in normal and crushed hypoglossal nerves. Brain Res 153:477-493.
109. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. 2004. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 67:87-107.
110. McMurry PH, Woo KS. 2002. Size distributions of 3 to 100 nm urban Atlanta aerosols: measurement and observations. J Aerosol Med 15(2):169-178.
111. Mehta D, Bhattacharya J, Matthay MA, Malik AB. 2004. Integrated control of lung fluid balance. Am J Physiol Lung Cell Mol Physiol 287:L1081-L1090.
112. Monteiro-Riviere N, Nemanich R, Inman A, Wang Y, Riviere J. 2005. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 155:377-384.
113. 2. Environ Sci Technol 38:1600-1604.
114. Nemmar A, Delaunois A, Nemery B, Dessy-Doize C, Beckers JF, Sulon J, et al. 1999. Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells. Toxicol Appl Pharmacol 160:250-261.
115. Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. 2002a. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414.
116. Nemmar A, Hoylaerts MF, Hoet PHM, Dinsdale D, Smith T, Xu H, et al. 2002b. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 166:998-1004.
117. Nemmar A, Hoylaerts MF, Hoet PHM, Vermylen J, Nemery B. 2003. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186:38-45.
118. Nghiem LD, Schäfer AI, Elimelech M. 2004. Removal of natural hormones by nanofiltration membranes: measurement, modeling, and mechanisms. Environ Sci Technol 38:1888-1896.
119. Nikula KJ, Avila KJ, Griffith WC, Mauderly JL. 1997. Lung tissue responses and sites of particle retention differ between rats and cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fundam Appl Toxicol 37:37-53.
120. NNI (National Nanotechnology Initiative). 2004. What Is Nanotechnology? Available: http://www.nano.gov/html/facts/whatIsNano.html [accessed 16 March 2005].
121. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC:National Academy Press.
122. Nuttall JB, Kelly RJ, Smith BS, Whiteside CK Jr. 1964. Inflight toxic reactions resulting from fluorocarbon resin pyrolysis. Aerospace Med 35:676-683.
123. Oberdörster E. 2004a. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in brain of juvenile largemouth bass. Environ Health Perspect 112:1058-1062.
124. Oberdörster E. 2004b. Toxicity of nC60 fullerenes to two aquatic species: Daphnia and largemouth bass [Abstract]. In: 227th American Chemical Society National Meeting, 27 March-1 April 2004, Anaheim, CA. Washington, DC:American Chemical Society, IEC 21.
125. Oberdörster G. 2000. Toxicology of ultrafine particles: in vivo studies. Philos Trans R Soc Lond A 358:2719-2740.
126. Oberdörster G, Ferin J, Finkelstein J, Wade P, Corson N. 1990. Increased pulmonary toxicity of ultrafine particles? II. Lung lavage studies. J Aerosol Sci 21:384-387.
127. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992a. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 97:193-197.
128. Oberdörster G, Ferin J, Morrow PE. 1992b. Volumetric loading of alveolar macrophages (AM): a possible basis for diminished AM-mediated particle clearance. Exp Lung Res 18:87-104.
129. Oberdörster G, Finkelstein A Johnston C, Gelein R, Cox C, Baggs R, et al. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 96:5-74.
130. Oberdörster G, Gelein RM, Ferin J, Weiss B. 1995. Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 7:111-124.
131. Oberdörster G, Morrow PE, Spurny K. 1988. Size dependent lymphatic short term clearance of amosite fibers in the lung. Ann Occup Hyg 32(suppl 4):149-156.
132. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16(6/7):437-445.
133. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. 2002. Extrapulmonary transloction of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health 65A:1531-1543.
134. Oberdörster G, Yu CP. 1990. The carcinogenic potential of inhaled diesel exhaust: a particle effect? J Aerosol Sci 21(suppl 1):S397-S401.
135. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, et al. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-288.
136. Oldfors A, Fardeau M. 1983. The permeability of the basal lamina at the neuromuscular junction. An ultrastructural study of rat skeletal muscle using particulate tracers. Neuropathol Appl Neurobiol 9:419-432.
137. Olsson T, Kristensson K. 1981. Neuronal uptake of iron: somatopetal axonal transport and fate of cationized and native ferretin, and iron-dextran after intramuscular injections. Neuropath Appl Neurobiol 7:87-95.
138. Patton JS. 1996. Review - mechanisms of macromolecule absorption bythe lungs. Adv Drug Deliv Rev 19:3-36.
139. Pekkanen J, Peters A, Hoek G, Tiittanen P, Brunekreef B, de Hartog J, et al. 2002. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease. The Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air [ULTRA] study. Circulation 106:933-938.
140. Pekkanen J, Timonen KL, Ruuskanen J, Reponen A, Mirme A. 1997. Effects of ultrafine and fine particles in urban air on peak expiratory flow among children with asthmatic symptoms. Environ Res 74:24-33.
141. Penttinen P, Timonen KL, Tiittanen P, Mirme A, Ruuskanen J, Pekkanen J. 2001. Ultrafine particles in urban air and respiratory health among adult asthmatics. Eur Resp J 17:428-435.
142. Peters A, Doring A, Wichmann H-E, Koenig W. 1997a. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 349:1582-1587.
143. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. 1997b. Respiratory effects are associated with the number of ultrafine particles. Am Respir Crit Care Med 155:1376-1383.
144. Pietropaoli AP, Frampton MW, Oberdörster G, Cox C, Huang L-S, Marder V, et al. Blood markers of coagulation and inflammation in healthy human subjects exposed to carbon ultrafine particles. In: Effects of Air Contaminants on the Respiratory Tract - Interpretations from Molecular to Meta Ananlysis (Heinrich U, ed). INIS Monographs. Stuttgart, Germany:Fraunhofer IRB Verlag, 181-194.
145. Plattig K-H. 1989. Electrophysiology of taste and smell. Clin Phys Physiol Meas 10:91-126.
146. Rancan F, Rosan S, Boehm F, Cantrell A, Brellreich M, Schoenberger H, et al. 2002. Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. J Photochem Photobiol B 67(3):157-162.
147. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159-169.
148. Rodoslav S, Laibin L, Eisenberg A, Dusica M. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618.
149. Sato K, Imai Y, Irimura RT. 1998. Contribution of dermal macrophage trafficking in the sensitization phase of contact hypersensitivity. J Immunol 161:6835-6844.
150. Sayes C, Fortner J, Guo W, Lyon D, Boyd AM, Ausman KD, et al. 2004. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4:1881-1887.
151. Schlesinger RB, Ben-Jebria A, Dahl AR, Snipes MB, Ultman J. 1997. Disposition of inhaled toxicants. In: Handbook of Human Toxicology (Massaro EJ, ed). New York:CRC Press, 493-550.
152. Schultheiss-Grassi PP, Wessiken R, Dobson J. 1999. TEM investigations of biogenic magnetite extracted from the human hippocampus. Biochim Biophys Acta 1426:212-216.
153. Seaton A, MacNee W, Donaldson K, Godden D. 1995. Particulate air pollution and acute health effects. Lancet 345:176-178.
154. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, et al. 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16:453-459.
155. Shi JP, Evans DE, Khan AA, Harrison RM. 2001. Sources and concentration of nanoparticles (< 10 nm diameer) in the urban atmosphere. Atmos Environ 35:1193-1202.
156. Shvedova AA, Kisin E, Keshava N, Murray AR, Gorelik O, Arepalli S, et al. 2004a. Cytotoxic and genotoxic effects of single wall carbon nanotube exposure on human keratinocytes and bronchial epithelial cells [Abstract]. In: 227th American Chemical Society National Meeting, 27 March-1 April 2004, Anaheim, CA. Washington, DC:American Chemical Society, IEC 20.
157. Shvedova AA, Kisin E, Murray A, Schwegler-Berry D, Gandelsman V, Baron P, et al. 2004b. Exposure of human bronchial cells to carbon nanotubes caused oxidative stress and cytotoxicity. In: Proceedings of the Meeting of the SFRR Europe 2004, Ioannina, Greece. Philadelphia:Taylor & Francis Group, 91-103.
158. Silva VM, Corson N, Elder A, Oberdörster G. In press. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci.
159. Simionescu N, Simionescu M, Palade GE. 1975. Permeability of muscle capillaries to small heme-peptides. J Cell Biol 64:586-607.
160. Smith AE, Helenius A. 2004. How viruses enter animal cells. Science 304:237-242
161. Terasaki S, Kameyama T, Yamamoto S. 1997. A case of zoster in the 2nd and 3rd branches of the trigeminal nerve associated with simultaneous herpes labialis infection - a case report. Kurume Med J 44(1):61-66.
162. Tiittanen P, Timonen KL, Ruuskanen J, Mirme A, Pekkanen J. 1999. Fine particulate air pollution, resuspended road dust and respiratory health among symptomatic children. Eur Resp J 13(2):266-273.
163. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, et al. 2003. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202-1208.
164. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. 2000. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 12:1113-1126.
165. Tran CL, Jones AD, Cullen RT, Donaldson K. 1998. Influence of particle characteristics on the clearance of low toxicity dusts from lungs. J Aerosol Sci 29(suppl 1):S1269-S1270.
166. Tungittiplakorn W, Lion LW, Cohen C, Kim J-Y. 2004. Engineered polymeric nanoparticles for soil remediation. Environ Sci Technol 38(5):1605-1610.
167. Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. 2003. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry 160(4):703-708.
168. U.S. EPA. 1994. 10-Day Chronic Daphnia magna or Daphnia pulex. SOP 2028. Washington DC:U.S. Environmental Protection Agency. Available: http://www.ert.org/products/2028.pdf [accessed 16 March 2005].
169. U.S. EPA. 2004. Air Quality Criteria for Particulate Matter. Vol 3. 600/P-95-001cF. Washington DC:U.S. Environmental Protection Agency, Office of Research and Development.
170. Utell M, Frampton M, Zareba W, Devlin R, Cascio W. 2002. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol 14:1231-1247.
171. -/- mice: VII. Degeneration of dopaminergic neurons. Inhal Toxicol.
172. von Klot S, Wolke G, Tuch T, Heinrich J, Dockery DW, Schwartz J, et al. 2002. Increased asthma medication use in association with ambient fine and ultrafine particles. Eur Respir J 20:691-702.
173. Warheit DB, Hartsky MA. 1993. Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species. Microsc Res Tech 26:412-422.
174. Warheit DB, Hill LH, George G, Brody AR. 1986. Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation. Am Rev Respir Dis 134:128-133.
175. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117-125.
176. Warheit DB, Overby LH, George G, Brody AR. 1988. Pulmonary macrophages are attracted to inhaled particles on alveolar surfaces. Exp Lung Res 14:51-66.
177. Waritz RS, Kwon BK. 1968. The inhalation toxicity of
178. WHO. 1985. Reference Methods for Measuring Airborne ManMade Mineral Fibers. Environmental Health Series 4. Copenhagen:World Health Organization.
179. Wichmann H-E, Cyrys J, Stölzel M, Spix C, Wittmaack K, Tuch T, et al. 2002. Sources and elemental composition of ambient particles in Erfurt, Germany. In: Fortschritte in der Umweltmedizin (Wichmann HE, Schlipköter HW, Fülgraff G, eds). Erfurt, Germany:Ecomed Publishers.
180. Wichmann H-E, Spix C, Tuch T, Wolke G, Peters A, Heinrich J, et al. 2000. Daily Mortality and Fine and Ultrafine Particles in Erfurt, Germany. Part I: Role of Particle Number and Particle Mass. Res Rep Health Eff Inst 98:5-86.
181. Widmaier EP, Raff H, Strang KT. 2004. Vander, Sherman & Luciano's Human Physiology: The Mechanisms of Body Functions. 9th ed. New York:McGraw Hill.
182. Williams N, Atkinson G, Patchefsky A. 1974. Polymer fume fever: not so benign. J Occup Med 16:519-522.
183. Wilson M, Lightbody J, Donaldson K, Sales J, Stone V. 2002. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 184(3):172-179.
184. Woo KS, Chen D-R, Pui D, McMurry P. 2001. Measurement of Atlanta aerosol size distributions: observations of ultrafine particle events. Aerosol Sci Technol 34:75-87.
185. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2:385-389.
186. 2. J Am Chem Soc 125:12803-12809.
187. Zhou Y-M, Zhong C-Y, Kennedy IM, Leppert VJ, Pinkerton KE. 2003. Oxidative stress and NFκB activation in the lungs of rats: a synergistic interaction between soot and iron particles. Toxicol Appl Pharmacol 190:157-169.
188. Zhu Y, Hinds WC, Kim S, Shen SK, Sioutas C. 2002. Study of ultrafine particles near a major highway with heavy-duty diesel traffic. Atmos Environ 36:4323-4335.